ADAMTS13 and anemia (phenotype): No significant differences were found in age, race, frequency of neurologic or renal abnormalities, severity of anemia and thrombocytopenia, or ADAMTS-13 activity (no patients had a severely deficient ADAMTS-13 activity ≤ 5%) [16].